- Home
- SNDX vs MFA Comparison
SNDX vs MFA Comparison
Compare SNDX & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- MFA
- Stock Information
- Founded
- SNDX 2005
- MFA 1997
- Country
- SNDX United States
- MFA United States
- Employees
- SNDX N/A
- MFA N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- MFA Real Estate Investment Trusts
- Sector
- SNDX Health Care
- MFA Real Estate
- Exchange
- SNDX Nasdaq
- MFA Nasdaq
- Market Cap
- SNDX 1.2B
- MFA 1.1B
- IPO Year
- SNDX 2016
- MFA N/A
- Fundamental
- Price
- SNDX $14.34
- MFA $10.55
- Analyst Decision
- SNDX Strong Buy
- MFA Buy
- Analyst Count
- SNDX 10
- MFA 5
- Target Price
- SNDX $36.20
- MFA $13.50
- AVG Volume (30 Days)
- SNDX 2.1M
- MFA 929.4K
- Earning Date
- SNDX 02-25-2025
- MFA 02-19-2025
- Dividend Yield
- SNDX N/A
- MFA 13.26%
- EPS Growth
- SNDX N/A
- MFA N/A
- EPS
- SNDX N/A
- MFA 1.60
- Revenue
- SNDX $16,000,000.00
- MFA $366,192,000.00
- Revenue This Year
- SNDX N/A
- MFA N/A
- Revenue Next Year
- SNDX N/A
- MFA $14.93
- P/E Ratio
- SNDX N/A
- MFA $6.60
- Revenue Growth
- SNDX N/A
- MFA 164.50
- 52 Week Low
- SNDX $12.06
- MFA $9.36
- 52 Week High
- SNDX $25.34
- MFA $13.45
- Technical
- Relative Strength Index (RSI)
- SNDX 54.69
- MFA 56.59
- Support Level
- SNDX $13.97
- MFA $10.06
- Resistance Level
- SNDX $13.16
- MFA $10.57
- Average True Range (ATR)
- SNDX 0.66
- MFA 0.19
- MACD
- SNDX 0.17
- MFA 0.08
- Stochastic Oscillator
- SNDX 85.39
- MFA 92.91
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company is an internally managed real estate investment trust or REIT.